12-2053560-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_000719.7(CACNA1C):c.-3T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000037 in 1,593,740 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000040 ( 2 hom. )
Consequence
CACNA1C
NM_000719.7 5_prime_UTR
NM_000719.7 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.17
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 12-2053560-T-C is Benign according to our data. Variant chr12-2053560-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 872566.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.0000395 (57/1441684) while in subpopulation MID AF= 0.000871 (5/5738). AF 95% confidence interval is 0.000343. There are 2 homozygotes in gnomad4_exome. There are 34 alleles in male gnomad4_exome subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAdExome4 at 57 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603 | c.-3T>C | 5_prime_UTR_variant | 1/47 | 5 | NM_001167623.2 | ENSP00000382512.1 | |||
CACNA1C | ENST00000399655 | c.-3T>C | 5_prime_UTR_variant | 1/47 | 1 | NM_000719.7 | ENSP00000382563.1 | |||
CACNA1C | ENST00000406454 | c.-3T>C | 5_prime_UTR_variant | 1/48 | 5 | ENSP00000385896.3 | ||||
CACNA1C | ENST00000399634 | c.-3T>C | 5_prime_UTR_variant | 1/47 | 5 | ENSP00000382542.2 | ||||
CACNA1C | ENST00000347598 | c.-3T>C | 5_prime_UTR_variant | 1/49 | 1 | ENSP00000266376.6 | ||||
CACNA1C | ENST00000327702 | c.-3T>C | 5_prime_UTR_variant | 1/48 | 1 | ENSP00000329877.7 | ||||
CACNA1C | ENST00000399617 | c.-3T>C | 5_prime_UTR_variant | 1/48 | 5 | ENSP00000382526.1 | ||||
CACNA1C | ENST00000335762 | c.-3T>C | 5_prime_UTR_variant | 1/48 | 5 | ENSP00000336982.5 | ||||
CACNA1C | ENST00000399641 | c.-3T>C | 5_prime_UTR_variant | 1/47 | 1 | ENSP00000382549.1 | ||||
CACNA1C | ENST00000682835 | c.-3T>C | 5_prime_UTR_variant | 1/47 | ENSP00000507282.1 | |||||
CACNA1C | ENST00000683482 | c.-3T>C | 5_prime_UTR_variant | 1/47 | ENSP00000507169.1 | |||||
CACNA1C | ENST00000682544.1 | c.140-61664T>C | intron_variant | ENSP00000507184.1 | ||||||
CACNA1C | ENST00000683824.1 | c.140-61664T>C | intron_variant | ENSP00000507867.1 | ||||||
CACNA1C | ENST00000682462.1 | c.140-61664T>C | intron_variant | ENSP00000507105.1 | ||||||
CACNA1C | ENST00000683781.1 | c.140-61664T>C | intron_variant | ENSP00000507434.1 | ||||||
CACNA1C | ENST00000683840.1 | c.140-61664T>C | intron_variant | ENSP00000507612.1 | ||||||
CACNA1C | ENST00000683956.1 | c.140-61664T>C | intron_variant | ENSP00000506882.1 | ||||||
CACNA1C | ENST00000480911.6 | n.-3T>C | non_coding_transcript_exon_variant | 1/27 | 5 | ENSP00000437936.2 | ||||
CACNA1C | ENST00000480911.6 | n.-3T>C | 5_prime_UTR_variant | 1/27 | 5 | ENSP00000437936.2 | ||||
CACNA1C | ENST00000344100.7 | c.-3T>C | upstream_gene_variant | 1 | ENSP00000341092.3 | |||||
CACNA1C | ENST00000399638.5 | c.-3T>C | upstream_gene_variant | 1 | ENSP00000382547.1 | |||||
CACNA1C | ENST00000399606.5 | c.-3T>C | upstream_gene_variant | 1 | ENSP00000382515.1 | |||||
CACNA1C | ENST00000399621.5 | c.-3T>C | upstream_gene_variant | 1 | ENSP00000382530.1 | |||||
CACNA1C | ENST00000399637.5 | c.-3T>C | upstream_gene_variant | 1 | ENSP00000382546.1 | |||||
CACNA1C | ENST00000402845.7 | c.-3T>C | upstream_gene_variant | 1 | ENSP00000385724.3 | |||||
CACNA1C | ENST00000399629.5 | c.-3T>C | upstream_gene_variant | 1 | ENSP00000382537.1 | |||||
CACNA1C | ENST00000682336.1 | c.-3T>C | upstream_gene_variant | ENSP00000507898.1 | ||||||
CACNA1C | ENST00000399591.5 | c.-3T>C | upstream_gene_variant | 1 | ENSP00000382500.1 | |||||
CACNA1C | ENST00000399595.5 | c.-3T>C | upstream_gene_variant | 1 | ENSP00000382504.1 | |||||
CACNA1C | ENST00000399649.5 | c.-3T>C | upstream_gene_variant | 1 | ENSP00000382557.1 | |||||
CACNA1C | ENST00000399597.5 | c.-3T>C | upstream_gene_variant | 1 | ENSP00000382506.1 | |||||
CACNA1C | ENST00000399601.5 | c.-3T>C | upstream_gene_variant | 1 | ENSP00000382510.1 | |||||
CACNA1C | ENST00000399644.5 | c.-3T>C | upstream_gene_variant | 1 | ENSP00000382552.1 | |||||
CACNA1C | ENST00000682686.1 | c.-3T>C | upstream_gene_variant | ENSP00000507309.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152056Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
2
AN:
152056
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000504 AC: 11AN: 218332Hom.: 0 AF XY: 0.0000678 AC XY: 8AN XY: 117980
GnomAD3 exomes
AF:
AC:
11
AN:
218332
Hom.:
AF XY:
AC XY:
8
AN XY:
117980
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000395 AC: 57AN: 1441684Hom.: 2 Cov.: 32 AF XY: 0.0000475 AC XY: 34AN XY: 715324
GnomAD4 exome
AF:
AC:
57
AN:
1441684
Hom.:
Cov.:
32
AF XY:
AC XY:
34
AN XY:
715324
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152056Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74274
GnomAD4 genome
AF:
AC:
2
AN:
152056
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
74274
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 22, 2021 | This variant is associated with the following publications: (PMID: 26582918, 27535533) - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 30, 2024 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at